CALL US AT: (949) 396-0330
CONNECT WITH NEMUS BIOSCIENCE INC.:

NEMUS Bioscience, Inc.

NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids.

SEC Filings

Date Filing Description Download
05-12-2017 10-Q Quarterly Report
05-12-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
05-04-2017 8-K Current report filing
03-28-2017 SC 13D/A Amended Statement of Beneficial Ownership
03-28-2017 4 Statement of Changes in Beneficial Ownership
03-23-2017 EFFECT Effectiveness Order
03-23-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
03-13-2017 S-1 Securities Registration Statement
03-10-2017 10-K Annual Report
02-08-2017 EFFECT Effectiveness Order
02-08-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
02-06-2017 CT ORDER Confidential Treatment Order
01-20-2017 S-1 Securities Registration Statement
01-20-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-20-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-20-2017 8-K/A Amended Current report filing
01-13-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-13-2017 8-K Current report filing
01-13-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-13-2017 D Small Company Offering and Sale of Securities Without Registration
01-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-11-2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
01-10-2017 8-K Current report filing